Prosecution Insights
Prosecution Insights
Tech Center 3600 • Art Units: 1600 1637 1681 3619
This examiner grants 65% of resolved cases
YOUNG J KIM is an examiner in Tech Center 3600, specifically assigned to Art Unit 1600. With 1124 resolved cases, this examiner has a history of patent evaluations that provides a statistical basis for predicting prosecution outcomes. Practitioners can observe the application of examination standards based on this track record in Art Unit 1600.
The examiner maintains an allowance rate of 64.8 percent, which reflects the frequency of successful outcomes for applications reaching a final resolution. The path to grant involves a median days to allowance of 1160. This duration indicates the time applications typically spend in the system before reaching an allowance. Applicants should plan their patent strategies around this 1160-day timeline to manage expectations regarding patent term and commercialization schedules in Tech Center 3600.
Engaging in interviews is a tactic to consider with this examiner, as evidenced by an interview lift of 18.1 percent. While the baseline allowance rate is 64.8 percent, the additional lift suggests that verbal communication helps resolve examiner concerns. Utilizing the 18.1 percent lift through interviewing can help navigate the median pendency and influence the probability of success for applications.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18837232 | ONE-POT ENDONUCLEOLYTICALLY EXPONENTIATED ROLLING CIRCLE AMPLIFICATION BY CRISPR-CAS12a | Non-Final OA | University of Florida Research Foundation, Inc. |
| 18653613 | METHODS AND COMPOSITIONS FOR SPATIAL ASSAY | Non-Final OA | 10x Genomics, Inc. |
| 17611788 | RAPID ANEUPLOIDY DETECTION | Final Rejection | The Johns Hopkins University |
| 18303700 | MICROFLUIDIC DEVICES AND OBSERVATION METHODS | Final Rejection | TOPPAN Inc. |
| 17879871 | Ultraspecific Nucleic Acid Sensors for Low-Cost Liquid Biopsies | Non-Final OA | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY |
| 18390463 | TARGETING OLIGONUCLEOTIDES AND METHODS OF USE THEREOF | Non-Final OA | Singular Genomics Systems, Inc. |
| 18537266 | CONTROLLED ROLLING CIRCLE AMPLIFICATION | Final Rejection | Singular Genomics Systems, Inc. |
| 17557010 | METHOD FOR PROVIDING QUANTITATIVE INFORMATION OF TARGETS AND DEVICE USING THE SAME | Final Rejection | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY |
| 18730043 | PREPARING NUCLEIC ACID FOR FURTHER ANALYSIS OF THEIR SEQUENCE | Non-Final OA | Becton, Dickinson and Company |
| 18686812 | USE OF DECOY POLYNUCLEOTIDES IN SINGLE CELL MULTIOMICS | Non-Final OA | Becton, Dickinson and Company |
| 18722508 | DETECTION OF GENETIC AND EPIGENETIC INFORMATION IN A SINGLE WORKFLOW | Non-Final OA | Foundation Medicine, Inc. |
| 18712646 | METHODS AND SYSTEMS FOR REPORTING CLINICALLY-ACTIONABLE POTENTIAL GERMLINE PATHOGENIC VARIANT SEQUENCES | Non-Final OA | Foundation Medicine, Inc. |
| 18689774 | GENE FUSIONS IN SARCOMA | Non-Final OA | Foundation Medicine, Inc. |
| 18561986 | ENHANCER OLIGONUCLEOTIDES FOR NUCLEIC ACID HYBRIDIZATION | Non-Final OA | Roche Sequencing Solutions, Inc |
| 18277760 | TAP63 REGULATED ONCOGENIC LONG NON-CODING RNAS | Non-Final OA | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. |
| 18889136 | NUCLEIC ACID DETECTION SYSTEM AND METHOD FOR DETECTING INFLUENZA | Non-Final OA | Triad National Security, LLC |
| 18147647 | COMPOSITIONS AND METHODS FOR IDENTIFYING CELL TYPES | Final Rejection | GRAIL, LLC |
| 18547904 | MARKERS OF PREDICTION OF RESPONSE TO CAR T CELL THERAPY | Final Rejection | INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy